Automated cell culture system: Sartorius Stedim CompacT SelecT APM or brand-name equal

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95019Q00318 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5- Simplified Procedures for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-05, effective August 13, 2019.
(iv) The associated NAICS code is 334516 and the small business size standard is 1,000 employees. This requirement has no set aside restrictions.
Description
(v) The National Center for Advancing Translational Sciences (NCATS) at the National Institues of Health (NIH) seeks to purchase one (1) Automated cell culture system: Sartorius Stedim CompacT SelecT APM or brand-name equal. This equipment shall be used to support novel assay development and validation screening.
The cell culture system must include one (1) of each of the following brand-name or equal items:
Item No. : Part No. : Part Name and/or Description

1 : 052-0001 : CompacT CellBase. The following features must be included:
• Flask incubator 130 T-75 or T-175 Flasks
• 6-axis Anthropomorphic Robot Arm
• Cell Counter
• Pumps for 10 media lines
• SelPlan scheduling and capacity planning software

2 : 052-0Z20 : CompacT Start-Up Kit
3 : 052-0H00 : Flask Confluency Module-Incucyte S3 Imager
4 : 052-0L84 : Processing of Nunc Triple Flasks
5 : 052-0L83 : Processing of Corning HYPERFlask
6 : 052-0C80 : Low Volume Reagent Dispensing
7 : 052-0W80 : E-mail Alerts
8 : 082-0W81 : User Defined Flask Types
9 : 052-0Z11 : Maintenance Spares Kit
10 : 052-0E22 : Transformer
11 : N/A : System delivery, installation, training, and operator spares
12 : N/A : One year of comprehensive service and support
The brand name or equal system must have the following salient characteristics:
1. The system must be capable of culturing multiple cell lines with cell line specific protocols.
2. It must be able to operate unattended, enabling more effective use of valuable resources.
3. The system must be able to culture delicate or complex cell lines such as stem cells and primary cells.b
4. The system must be capable of maintaining stock cell lines for multiple projects.
5. The system must facilitate the output of cells to an external collection vessel allowing multiple flasks to be to be harvested and pooled without restricting the volume of cell suspension that can be collected.
6. The system must be equipped with a cooled reagent storage system (6°C / 43°F) to enable low volume dispensing (100 - 1,000μL) for up to 6 reagents such as growth factors and transfection mixes to flasks.
7. The system must have the ability to process Corning HYPERFlasks, providing a 10-fold increase in cell production capability.
8. The system must be able to send system updates via email.
9. The system must automatically back up valuable information to remote media.
10. The system must allow users to generate custom formatted reports.
11. The system must enable direct imaging of cells in flasks, confluence measurement and enhanced QA of cells.
(vi) Delivery is to occur within 12 months after receipt of order, to the below address with FOB Destination.
National Center for the Advancement of Translational Sciences
9800 Medical Center Drive
Rockville, MD 20850
Evaluation and Award
(vii) The Government plans to award a contract resulting from this solicitation. The resulting award will be made to the responsible offeror whose offer will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotations: Technical Capability, Past Performance, and Price. Comparative evaluations will be conducted if multiple quotations are received.
(viii) The anticipated award date is September 6, 2019.
Vendor and Submission Requirements
(ix) Offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
(x) Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the brand-name or equal equipment. Responses must also include the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), the certification of business size, and the completed offeror representation in FAR Provision 52.204-24 (attached).
(xi) The price quote must include, as applicable: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, product or catalog number(s); product description; what the warranty covers; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.
(xii) All responses must be received by 8:59am EDT on September 3, 2019, and reference solicitation number 75N95019Q00318. Responses must be submitted via email to Kimberly Espinosa, Contract Specialist, at kimberly.espinosa@nih.gov, with a copy to Hunter Tjugum, Contracting Officer, at hunter.tjugum@nih.gov.
(xiii) For information regarding the solicitation, contact Kimberly Espinosa, Contract Specialist, at 301-827-3546 or kimberly.espinosa@nih.gov.
(xiv) All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.
Post Award Evaluation of Contractor Performance
(xv) Contractor performance evaluations: Interim and Final evaluations of Contractor performance will be prepared on this contract in accordance with FAR Subpart 42.15. The Final performance evaluation will be prepared at the time of completion of work. The Final evaluation will be provided to the Contractor as soon as practicable after completion of the evaluation. The Contractor will be permitted fourteen days to review the document and to submit additional information or a rebutting statement. If agreement cannot be reached between the parties, the matter will be referred to an individual one level above the Contracting Officer, whose decision will be final.
Copies of the evaluations, Contractor responses, and review comments, if any, will be retained as part of the contract file, and may be used to support future award decisions.
(xvi) Electronic access to contractor performance evaluations: Contractors may access evaluations through a secure Web site for review and comment at: http://www.cpars.gov.
Provisions and Clauses
(xvii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998). This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at www.acquisition.gov.
The following provisions apply to this acquisition and are incorporated by reference:
• The provision at FAR 52.204-7, System for Award Management (Oct 2018)
• The provision at FAR 52.204-16, Commercial and Government Entity Code Reporting (Jul 2016)
• The provision at FAR 52.211-6, Brand Name or Equal (Aug 1999)
• The provision at FAR 52.212-1, Instructions to Offerors - Commercial Items (Oct 2018)
• The provision at 52.212-3, Offeror Representations and Certifications-Commercial Items (Oct 2018)
(xviii) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998). This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at www.acquisition.gov.
In addition to the clauses checked in FAR 52.212-5 (attached), the following clauses also apply to this acquisition and are incorporated by reference:
• The clause at FAR 52.204-13, System for Award Management Maintenance (Oct 2018)
• The clause at FAR 52.204-18, Commercial and Government Entity Code Maintenance (Jul 2016)
• The clause at FAR 52.212-4, Contract Terms and Conditions - Commercial Items (Oct 2018)
• The clause at HHSAR 352.222-70, Contractor Cooperation in Equal Employement Opportunity Investigations (December 18, 2015)
(xix) The following provisions and clauses apply to this acquisition and are attached in full text:
• The provision at FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2019)
• Addendum to the clause at FAR 52.212-4, Contract Terms and Conditions - Commercial Items (Oct 2018)
• The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Aug 2019)
• NIH Invoice and Payment Provisions (2/2014)
(xx) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition.
(xxi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.

.

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95019Q00318 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5- Simplified Procedures for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-05, effective August 13, 2019.
(iv) The associated NAICS code is 334516 and the small business size standard is 1,000 employees. This requirement has no set aside restrictions.
Description
(v) The National Center for Advancing Translational Sciences (NCATS) at the National Institues of Health (NIH) seeks to purchase one (1) Automated cell culture system: Sartorius Stedim CompacT SelecT APM or brand-name equal. This equipment shall be used to support novel assay development and validation screening.
The cell culture system must include one (1) of each of the following brand-name or equal items:
Item No. : Part No. : Part Name and/or Description

1 : 052-0001 : CompacT CellBase. The following features must be included:
• Flask incubator 130 T-75 or T-175 Flasks
• 6-axis Anthropomorphic Robot Arm
• Cell Counter
• Pumps for 10 media lines
• SelPlan scheduling and capacity planning software

2 : 052-0Z20 : CompacT Start-Up Kit
3 : 052-0H00 : Flask Confluency Module-Incucyte S3 Imager
4 : 052-0L84 : Processing of Nunc Triple Flasks
5 : 052-0L83 : Processing of Corning HYPERFlask
6 : 052-0C80 : Low Volume Reagent Dispensing
7 : 052-0W80 : E-mail Alerts
8 : 082-0W81 : User Defined Flask Types
9 : 052-0Z11 : Maintenance Spares Kit
10 : 052-0E22 : Transformer
11 : N/A : System delivery, installation, training, and operator spares
12 : N/A : One year of comprehensive service and support
The brand name or equal system must have the following salient characteristics:
1. The system must be capable of culturing multiple cell lines with cell line specific protocols.
2. It must be able to operate unattended, enabling more effective use of valuable resources.
3. The system must be able to culture delicate or complex cell lines such as stem cells and primary cells.b
4. The system must be capable of maintaining stock cell lines for multiple projects.
5. The system must facilitate the output of cells to an external collection vessel allowing multiple flasks to be to be harvested and pooled without restricting the volume of cell suspension that can be collected.
6. The system must be equipped with a cooled reagent storage system (6°C / 43°F) to enable low volume dispensing (100 - 1,000μL) for up to 6 reagents such as growth factors and transfection mixes to flasks.
7. The system must have the ability to process Corning HYPERFlasks, providing a 10-fold increase in cell production capability.
8. The system must be able to send system updates via email.
9. The system must automatically back up valuable information to remote media.
10. The system must allow users to generate custom formatted reports.
11. The system must be able to generate assay-ready plates for cell-based screening and assay development. Must be capable of processing 6, 24, 96 and 384-well standard plates and also 24 and 96-well insert plates.
12. The system must be equipped with a barcode reader on the plating module to track plates during operation.
13. The system must enable direct imaging of cells in flasks, confluence measurement and enhanced QA of cells.
(vi) Delivery is to occur within 12 months after receipt of order, to the below address with FOB Destination.
National Center for the Advancement of Translational Sciences
9800 Medical Center Drive
Rockville, MD 20850
Evaluation and Award
(vii) The Government plans to award a contract resulting from this solicitation. The resulting award will be made to the responsible offeror whose offer will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotations: Technical Capability, Past Performance, and Price. Comparative evaluations will be conducted if multiple quotations are received.
(viii) The anticipated award date is September 6, 2019.
Vendor and Submission Requirements
(ix) Offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
(x) Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the brand-name or equal equipment. Responses must also include the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), the certification of business size, and the completed offeror representation in FAR Provision 52.204-24 (attached).
(xi) The price quote must include, as applicable: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, product or catalog number(s); product description; what the warranty covers; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.
(xii) All responses must be received by 8:59am EDT on September 3, 2019, and reference solicitation number 75N95019Q00318. Responses must be submitted via email to Kimberly Espinosa, Contract Specialist, at kimberly.espinosa@nih.gov, with a copy to Hunter Tjugum, Contracting Officer, at hunter.tjugum@nih.gov.
(xiii) For information regarding the solicitation, contact Kimberly Espinosa, Contract Specialist, at 301-827-3546 or kimberly.espinosa@nih.gov.
(xiv) All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.
Post Award Evaluation of Contractor Performance
(xv) Contractor performance evaluations: Interim and Final evaluations of Contractor performance will be prepared on this contract in accordance with FAR Subpart 42.15. The Final performance evaluation will be prepared at the time of completion of work. The Final evaluation will be provided to the Contractor as soon as practicable after completion of the evaluation. The Contractor will be permitted fourteen days to review the document and to submit additional information or a rebutting statement. If agreement cannot be reached between the parties, the matter will be referred to an individual one level above the Contracting Officer, whose decision will be final.
Copies of the evaluations, Contractor responses, and review comments, if any, will be retained as part of the contract file, and may be used to support future award decisions.
(xvi) Electronic access to contractor performance evaluations: Contractors may access evaluations through a secure Web site for review and comment at: http://www.cpars.gov.
Provisions and Clauses
(xvii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998). This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at www.acquisition.gov.
The following provisions apply to this acquisition and are incorporated by reference:
• The provision at FAR 52.204-7, System for Award Management (Oct 2018)
• The provision at FAR 52.204-16, Commercial and Government Entity Code Reporting (Jul 2016)
• The provision at FAR 52.211-6, Brand Name or Equal (Aug 1999)
• The provision at FAR 52.212-1, Instructions to Offerors - Commercial Items (Oct 2018)
• The provision at 52.212-3, Offeror Representations and Certifications-Commercial Items (Oct 2018)
(xviii) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998). This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at www.acquisition.gov.
In addition to the clauses checked in FAR 52.212-5 (attached), the following clauses also apply to this acquisition and are incorporated by reference:
• The clause at FAR 52.204-13, System for Award Management Maintenance (Oct 2018)
• The clause at FAR 52.204-18, Commercial and Government Entity Code Maintenance (Jul 2016)
• The clause at FAR 52.212-4, Contract Terms and Conditions - Commercial Items (Oct 2018)
• The clause at HHSAR 352.222-70, Contractor Cooperation in Equal Employement Opportunity Investigations (December 18, 2015)
(xix) The following provisions and clauses apply to this acquisition and are attached in full text:
• The provision at FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2019)
• Addendum to the clause at FAR 52.212-4, Contract Terms and Conditions - Commercial Items (Oct 2018)
• The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Aug 2019)
• NIH Invoice and Payment Provisions (2/2014)
(xx) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition.
(xxi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.

.

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95019Q00318 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5- Simplified Procedures for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-05, effective August 13, 2019.
(iv) The associated NAICS code is 334516 and the small business size standard is 1,000 employees. This requirement has no set aside restrictions.
Description
(v) The National Center for Advancing Translational Sciences (NCATS) at the National Institues of Health (NIH) seeks to purchase one (1) Automated cell culture system: Sartorius Stedim CompacT SelecT APM or brand-name equal. This equipment shall be used to support novel assay development and validation screening.
The cell culture system must include one (1) of each of the following brand-name or equal items:
Item No. : Part No. : Part Name and/or Description

1 : 052-0001 : CompacT CellBase. The following features must be included:
• Flask incubator 130 T-75 or T-175 Flasks
• 6-axis Anthropomorphic Robot Arm
• Cell Counter
• Pumps for 10 media lines
• SelPlan scheduling and capacity planning software

2 : 052-0Z20 : CompacT Start-Up Kit
3 : 052-0H00 : Flask Confluency Module-Incucyte S3 Imager
4 : 052-0L84 : Processing of Nunc Triple Flasks
5 : 052-0L83 : Processing of Corning HYPERFlask
6 : 052-0C80 : Low Volume Reagent Dispensing
7 : 052-0W80 : E-mail Alerts
8 : 082-0W81 : User Defined Flask Types
9 : 052-0Z11 : Maintenance Spares Kit
10 : N/A : System delivery, installation, training, and operator spares
11 : N/A : One year of comprehensive service and support
The brand name or equal system must have the following salient characteristics:
1. The system must be capable of culturing multiple cell lines with cell line specific protocols.
2. It must be able to operate unattended, enabling more effective use of valuable resources.
3. The system must be able to culture delicate or complex cell lines such as stem cells and primary cells.b
4. The system must be capable of maintaining stock cell lines for multiple projects.
5. The system must facilitate the output of cells to an external collection vessel allowing multiple flasks to be to be harvested and pooled without restricting the volume of cell suspension that can be collected.
6. The system must be equipped with a cooled reagent storage system (6°C / 43°F) to enable low volume dispensing (100 - 1,000μL) for up to 6 reagents such as growth factors and transfection mixes to flasks.
7. The system must have the ability to process Corning HYPERFlasks, providing a 10-fold increase in cell production capability.
8. The system must be able to send system updates via email.
9. The system must automatically back up valuable information to remote media.
10. The system must allow users to generate custom formatted reports.
11. The system must be able to generate assay-ready plates for cell-based screening and assay development. Must be capable of processing 6, 24, 96 and 384-well standard plates and also 24 and 96-well insert plates.
12. The system must be equipped with a barcode reader on the plating module to track plates during operation.
13. The system must enable direct imaging of cells in flasks, confluence measurement and enhanced QA of cells.
(vi) Delivery is to occur within 12 months after receipt of order, to the below address with FOB Destination.
National Center for the Advancement of Translational Sciences
9800 Medical Center Drive
Rockville, MD 20850
Evaluation and Award
(vii) The Government plans to award a contract resulting from this solicitation. The resulting award will be made to the responsible offeror whose offer will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotations: Technical Capability, Past Performance, and Price. Comparative evaluations will be conducted if multiple quotations are received.
(viii) The anticipated award date is September 6, 2019.
Vendor and Submission Requirements
(ix) Offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
(x) Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the brand-name or equal equipment. Responses must also include the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), the certification of business size, and the completed offeror representation in FAR Provision 52.204-24 (attached).
(xi) The price quote must include, as applicable: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, product or catalog number(s); product description; what the warranty covers; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.
(xii) All responses must be received by 8:59am EDT on September 3, 2019, and reference solicitation number 75N95019Q00318. Responses must be submitted via email to Kimberly Espinosa, Contract Specialist, at kimberly.espinosa@nih.gov, with a copy to Hunter Tjugum, Contracting Officer, at hunter.tjugum@nih.gov.
(xiii) For information regarding the solicitation, contact Kimberly Espinosa, Contract Specialist, at 301-827-3546 or kimberly.espinosa@nih.gov.
(xiv) All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.
Post Award Evaluation of Contractor Performance
(xv) Contractor performance evaluations: Interim and Final evaluations of Contractor performance will be prepared on this contract in accordance with FAR Subpart 42.15. The Final performance evaluation will be prepared at the time of completion of work. The Final evaluation will be provided to the Contractor as soon as practicable after completion of the evaluation. The Contractor will be permitted fourteen days to review the document and to submit additional information or a rebutting statement. If agreement cannot be reached between the parties, the matter will be referred to an individual one level above the Contracting Officer, whose decision will be final.
Copies of the evaluations, Contractor responses, and review comments, if any, will be retained as part of the contract file, and may be used to support future award decisions.
(xvi) Electronic access to contractor performance evaluations: Contractors may access evaluations through a secure Web site for review and comment at: http://www.cpars.gov.
Provisions and Clauses
(xvii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998). This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at www.acquisition.gov.
The following provisions apply to this acquisition and are incorporated by reference:
• The provision at FAR 52.204-7, System for Award Management (Oct 2018)
• The provision at FAR 52.204-16, Commercial and Government Entity Code Reporting (Jul 2016)
• The provision at FAR 52.211-6, Brand Name or Equal (Aug 1999)
• The provision at FAR 52.212-1, Instructions to Offerors - Commercial Items (Oct 2018)
• The provision at 52.212-3, Offeror Representations and Certifications-Commercial Items (Oct 2018)
(xviii) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998). This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at www.acquisition.gov.
In addition to the clauses checked in FAR 52.212-5 (attached), the following clauses also apply to this acquisition and are incorporated by reference:
• The clause at FAR 52.204-13, System for Award Management Maintenance (Oct 2018)
• The clause at FAR 52.204-18, Commercial and Government Entity Code Maintenance (Jul 2016)
• The clause at FAR 52.212-4, Contract Terms and Conditions - Commercial Items (Oct 2018)
• The clause at HHSAR 352.222-70, Contractor Cooperation in Equal Employement Opportunity Investigations (December 18, 2015)
(xix) The following provisions and clauses apply to this acquisition and are attached in full text:
• The provision at FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2019)
• Addendum to the clause at FAR 52.212-4, Contract Terms and Conditions - Commercial Items (Oct 2018)
• The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Aug 2019)
• NIH Invoice and Payment Provisions (2/2014)
(xx) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition.
(xxi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.

.